1. India Stocks

  2. •

    Distribution services

  3. •

    Food distributors
Unjha Formulations Limited

Unjha Formulations Limited

BBSE:UNJHAFOR
29.05
INR
-0.57
(-1.92%)
1.05EPS
18.89P/E
88.98MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
14.94
20.05
22.96
27.34
25.38
25.49
23.72
22.11
31.41
29.33
41.26
30.96
34.72
34.05
Basic EPS, GAAP
0.28
0.39
0.57
0.66
0.59
0.67
0.69
0.23
0.56
0.63
0.62
0.91
1.57
1.05
Free Cash Flow per Basic Share
0.9
-1.77
0.86
0.23
0.3
-0.27
0.65
-1.71
0.82
-0.8
2.05
-0.5
2.25
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.48
0.87
1.45
2.11
2.69
3.36
4.05
4.28
5.48
5.48
6.1
7.01
8.58
- -
Tangible Book Value per Share
-0.63
-0.24
0.33
0.99
1.58
2.25
2.93
3.17
4.36
4.36
4.98
5.89
7.46
- -
Basic Weighted Avg Shares
4
4
5
4
4
4
4
5
5
4
4
4
4
4
Sales/Revenue/Turnover
66
89
104
122
113
114
106
100
142
132
185
139
156
153
Operating Margin (%)
1.95
1.78
3.36
2.37
2.32
3.91
1.71
2.41
1.8
2.71
2.67
3.01
5.12
4.36
Depreciation Expense
1
1
1
1
1
1
1
1
1
1
1
1
1
2
Net Income, GAAP
1
2
3
3
3
3
3
1
3
3
3
4
7
5
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
15.72
14.29
38.49
22.16
26.12
34.56
Profit Margin (%)
1.87
1.94
2.48
2.41
2.32
2.63
2.91
1.04
1.78
2.15
1.5
2.94
4.52
3.09
Working Capital
-11
-9
-6
-5
-2
4
7
8
14
14
16
19
25
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
2
4
6
9
12
15
18
19
25
25
27
31
38
- -
Return on Invested Capital (%)
75.83
34.48
35.76
36.1
23.87
15.77
10.93
12.84
9.81
12.38
11.62
11.02
16.85
- -
Return on Capital (%)
78.79
35.13
48.51
46.82
24.4
22.5
25.26
14.25
16.66
13.13
11.94
13.92
20.2
- -
Return on Common Equity (%)
75.83
57.18
49.54
37.14
24.43
22.14
18.57
5.55
11.55
11.52
10.72
13.88
20.19
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
5
4
4
Market Capitalization
113
91
89

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
42
- -
Cash, Cash Equivalents & STI
- -
16
- -
Accounts Receivable, Net
- -
13
- -
Inventories
- -
6
- -
Total Current Liabilities
- -
17
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
22.45%
Free Cash Flow
-230.81%
-274.36%
-546.81%
Net Income, GAAP
22.8%
54.74%
72.93%
Sales/Revenue/Turnover
6.13%
12.63%
12.43%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
40
38
38
24
139
2026
36
43
44
33
156
2027
33
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1.56
-0.25
0.5
-0.91
0.91
2026
0.87
1.83
0.53
-1.66
1.57
2027
0.35
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Krutiben Mayankkumar Patel
Full Time Employees
17
Sector
Distribution services
Industry
Food distributors
Address
Khali Char Rasta Sidhpur GU India 384151
IPO Date
Mar 7, 1996
Website
unjhaformulations.com
Similar Companies
Itochu Corporation (TSE:8001)
Sysco Corporation (NYSE:SYY)
The Chefs' Warehouse, Inc. (NASDAQ:CHEF)
Krispy Kreme, Inc. (NASDAQ:DNUT)
US Foods Holding Corp. (NYSE:USFD)
Vanet Gida Sanayi Ic ve Dis Ticaret AS (BIST:VANGD)
Business
Unjha Formulations Limited manufactures and sells ayurvedic products, specializing in Isabgol (psyllium) formulations, in India. The company offers sat-isabgol and isabgol husk in elaichi flavor under the Anchor brand; isabgol powder in orange flavor under the Fibron and Fibron SF brands; and additional pharmaceutical formulations including liquids, powders, tablets, capsules, and injectibles for human consumption and veterinary use. It operates a GMP-certified facility focused on hygienic sat-isabgol, isabgol husk, and natural fibre drinks, with exports to international markets. Founded in 1991 and headquartered in Sidhpur, Gujarat, the company serves the healthcare pharmaceuticals and biotechnology segment, targeting consumers seeking ayurvedic remedies for digestive health and related conditions. It functions as part of M/s Urvesh Ltd., a parent entity engaged in exporting isabgol husk and powder as a 100% export-oriented unit. Operations emphasize quality control through physico-chemical and microbiological testing at its modern plant. In recent developments, Unjha Formulations reported positive financial results for Q2 fiscal 2024-2025, with increased profit after tax and higher operating cash flow despite lower PBDIT and PBT; it held its 31st annual general meeting on August 13, 2025, approving all resolutions unanimously and appointing Ajay Parikh & Associates as secretarial auditor for fiscal 2025-26 through 2029-30. The company submitted updated financial statements, including balance sheet, P&L, and cash flow as of March 31, 2025, in compliance with SEBI regulations, and filed its distribution schedule post-AGM. It maintains a low-debt profile with ROCE at 18.1% and focuses on domestic expansion amid modest sales growth.